Literature DB >> 24193373

Prevention of post-ERCP pancreatitis.

Jennifer Maranki1, Paul Yeaton.   

Abstract

Pancreatitis is one of the most common complications of endoscopic retrograde cholangiopancreatography (ERCP). A variety of patient-related and procedure-related factors have been identified to risk-stratify patients. Several measures can be undertaken in order to decrease the risk of post-ERCP pancreatitis in high-risk groups. These measures include pancreatic duct stenting and rectal indomethacin, amongst others.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24193373     DOI： 10.1007/s11894-013-0352-2

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN： 1522-8037


  80 in total

1.  Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones.

Authors:  James A Disario; Martin L Freeman; David J Bjorkman; Padraic Macmathuna; Bret T Petersen; Philip E Jaffe; Thomas G Morales; Lee J Hixson; Stuart Sherman; Glen A Lehman; M Mazen Jamal; Firas H Al-Kawas; Mukul Khandelwal; Joseph P Moore; Gregory A Derfus; Priya A Jamidar; Francisco C Ramirez; Michael E Ryan; Karen L Woods; David L Carr-Locke; Stephen C Alder
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

Review 2.  A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis.

Authors:  B J Elmunzer; A K Waljee; G H Elta; J R Taylor; S M A Fehmi; P D R Higgins
Journal:  Gut       Date:  2008-03-28       Impact factor: 23.059

3.  Impact of introduction of wire-guided cannulation in therapeutic biliary endoscopic retrograde cholangiopancreatography.

Authors:  Yousuke Nakai; Hiroyuki Isayama; Takeshi Tsujino; Naoki Sasahira; Kenji Hirano; Hirofumi Kogure; Takashi Sasaki; Kazumichi Kawakubo; Hiroshi Yagioka; Yoko Yashima; Suguru Mizuno; Keisuke Yamamto; Toshihiko Arizumi; Osamu Togawa; Saburo Matsubara; Natsuyo Yamamoto; Minoru Tada; Masao Omata; Kazuhiko Koike
Journal:  J Gastroenterol Hepatol       Date:  2011-10       Impact factor: 4.029

4.  Risk factors for post-ERCP pancreatitis: a prospective multicenter study.

Authors:  Chi-Liang Cheng; Stuart Sherman; James L Watkins; Jeffrey Barnett; Martin Freeman; Joseph Geenen; Michael Ryan; Harrison Parker; James T Frakes; Evan L Fogel; William B Silverman; Kulwinder S Dua; Giuseppe Aliperti; Paul Yakshe; Michael Uzer; Whitney Jones; John Goff; Laura Lazzell-Pannell; Abdullah Rashdan; M'hamed Temkit; Glen A Lehman
Journal:  Am J Gastroenterol       Date:  2006-01       Impact factor: 10.864

5.  Risk of post-ERCP pancreatitis with placement of self-expandable metallic stents.

Authors:  Gregory A Coté; Nitin Kumar; Michael Ansstas; Steven A Edmundowicz; Sreenivasa Jonnalagadda; Daniel K Mullady; Riad R Azar
Journal:  Gastrointest Endosc       Date:  2010-07-13       Impact factor: 9.427

6.  The results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone (Tokyo P3R): a multicenter, randomized, phase II, non-placebo-controlled trial.

Authors:  Takeshi Tsujino; Hiroyuki Isayama; Yousuke Nakai; Yukiko Ito; Osamu Togawa; Nobuo Toda; Toshihiko Arizumi; Hirofumi Kogure; Keisuke Yamamoto; Suguru Mizuno; Yoko Yashima; Hiroshi Yagioka; Takashi Sasaki; Saburo Matsubara; Natsuyo Yamamoto; Kenji Hirano; Naoki Sasahira; Minoru Tada; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2012-10-24       Impact factor: 7.527

7.  Significant clinical implications of prophylactic pancreatic stent placement in previously normal pancreatic ducts.

Authors:  Y G Bakman; K Safdar; M L Freeman
Journal:  Endoscopy       Date:  2009-11-10       Impact factor: 10.093

8.  Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years.

Authors:  Peter B Cotton; Donald A Garrow; Joseph Gallagher; Joseph Romagnuolo
Journal:  Gastrointest Endosc       Date:  2009-03-14       Impact factor: 9.427

9.  Pancreatic stents can induce ductal changes consistent with chronic pancreatitis.

Authors:  R A Kozarek
Journal:  Gastrointest Endosc       Date:  1990 Mar-Apr       Impact factor: 9.427

10.  Antioxidant supplementation for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.

Authors:  Wan-Jie Gu; Chun-Yin Wei; Rui-Xing Yin
Journal:  Nutr J       Date:  2013-02-11       Impact factor: 3.271
View more
  3 in total

Review 1.  Endoscopic retrograde cholangiopancreatography-related perforation: Management and prevention.

Authors:  Varayu Prachayakul; Pitulak Aswakul
Journal:  World J Clin Cases       Date:  2014-10-16       Impact factor: 1.337

2.  A Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in Patients with Suspected Type 3 Sphincter of Oddi Dysfunction.

Authors:  Ali A Siddiqui; Devi Patel; Jeremy Kaplan; Andrew H Zabolotsky; David Loren; Thomas Kowalski; Saad S Ghumman; Douglas G Adler; Satish Munigal; Umar Hayat; Mohamad A Eloubeidi
Journal:  Dig Dis Sci       Date:  2015-04-14       Impact factor: 3.199

3.  Targeted inhibition of pancreatic acinar cell calcineurin is a novel strategy to prevent post-ERCP pancreatitis.

Authors:  Abrahim I Orabi; Li Wen; Tanveer A Javed; Tianming Le; Ping Guo; Subramaniam Sanker; David Ricks; Kristy Boggs; John F Eisses; Carlos Castro; Xiangwei Xiao; Krishna Prasadan; Farzad Esni; George K Gittes; Sohail Z Husain
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.